Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.
Clinical trial NCT02296138 · COMPLETED
Trial details
- NCT number
- NCT02296138
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-13
- Primary completion
- 2017-03-08
- Enrollment
- 7903
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.